Measles Virus: Symptoms, Prevention, and Treatment

Measles is a highly contagious viral infection that remains a significant public health concern despite being preventable through vaccination. This article provides a comprehensive overview of the measles virus, its symptoms, transmission, prevention strategies, and available treatments, based on the latest information available as of March 1, 2026.

What is the Measles Virus?

The measles virus, scientifically known as Morbillivirus, is a single-stranded RNA virus belonging to the Paramyxoviridae family. It is the causative agent of measles, a disease that can lead to severe health complications, particularly in young children and individuals with weakened immune systems. Before the widespread use of the measles vaccine, measles was a common childhood illness globally.

According to the World Health Organization (WHO), measles vaccinations have prevented an estimated 56 million deaths globally between 2000 and 2021 WHO Measles Fact Sheet, highlighting the critical impact of immunization.

Symptoms and Transmission of Measles Virus

Measles virus infection typically begins with a prodromal phase lasting 2-4 days, characterized by symptoms that appear before the rash. These initial symptoms are due to the virus replicating in the respiratory tract and lymphatic system and include:

• High fever (often exceeding 103°F or 39.4°C)
• Cough
• Runny nose (coryza)
• Red, watery eyes (conjunctivitis)
• Koplik’s spots: tiny white spots with bluish-white centers on a red background found inside the mouth, often appearing 1-2 days before the rash.

A few days after the initial symptoms, a characteristic red, blotchy rash emerges, typically starting on the face and behind the ears, then spreading downwards to the rest of the body. The rash can last for 5-6 days.

The measles virus spreads through respiratory droplets when an infected person coughs or sneezes. These airborne droplets can remain infectious in the air for up to two hours after the infected person has left the area. This makes measles one of the most contagious infectious diseases known, with a basic reproduction number (R0) often cited between 12 and 18 in unvaccinated populations, meaning one infected person can infect 12 to 18 others.

Preventing and Treating Measles Virus Infection

The most effective method of preventing measles is vaccination. The measles, mumps, and rubella (MMR) vaccine is a safe and highly effective vaccine that provides long-lasting immunity against the measles virus. The Centers for Disease Control and Prevention (CDC) recommends two doses of the MMR vaccine for children: the first dose at 12–15 months of age and the second dose at 4–6 years of age CDC Measles Vaccination.

Adults who have not been vaccinated or had measles should also consider vaccination. High vaccination rates are essential to achieve herd immunity, which protects vulnerable individuals who cannot be vaccinated.

There is no specific antiviral treatment for measles virus infection. Treatment is primarily supportive, focusing on managing symptoms and preventing complications. This includes rest, hydration, and fever-reducing medications (e.g., acetaminophen or ibuprofen). Vitamin A supplementation, especially in children in developing countries, has been shown to reduce the severity and mortality of measles.

In severe cases, hospitalization may be required to manage complications such as pneumonia, encephalitis, or severe dehydration. Prompt medical attention is vital for anyone suspected of having measles, particularly those at high risk for complications.

Measles Outbreaks and Current Status

Due to a highly effective vaccination program, measles was declared eliminated from the U.S. In 2000, a historic public health achievement. However, outbreaks related to vaccine hesitancy have been occurring worldwide in recent years. In the U.S., more than 2,000 cases of measles were reported in 2025, the most number of cases since measles was declared eliminated in 2000 IDSA Measles Facts.

Key Takeaways

• Measles is a highly contagious viral infection preventable through vaccination.
• Symptoms include fever, cough, runny nose, red eyes, Koplik’s spots, and a characteristic rash.
• The MMR vaccine is highly effective and recommended in two doses for children.
• There is no specific antiviral treatment. care focuses on symptom management and preventing complications.
• Vaccination is crucial for achieving herd immunity and protecting vulnerable populations.